1
/
의
1
Cloud-clone
SKU(재고 관리 코드):MAA519Hu22
Monoclonal Antibody to Apolipoprotein A1 (APOA1)
Monoclonal Antibody to Apolipoprotein A1 (APOA1)
Western blotting: 0.5-3µg/mL;
;Immunohistochemistry: 5-30µg/mL;
;Immunocytochemistry: 5-30µg/mL;
;Optimal working dilutions must be determined by end user.
;Immunohistochemistry: 5-30µg/mL;
;Immunocytochemistry: 5-30µg/mL;
;Optimal working dilutions must be determined by end user.
Product No.
MAA519Hu22
Organism Species
Homo sapiens (Human)
Source
Monoclonal antibody preparation
Host
Mouse
Potency (Clone Number)
C10
Ig Isotype
IgG2b Kappa
Purification
Protein A + Protein G affinity chromatography
Label
None
Immunogen
RPA519Hu01-Recombinant Apolipoprotein A1 (APOA1)
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
1mg/ml
Organism Species More
n/a
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a mouse monoclonal antibody raised against APOA1. It has been selected for its ability to recognize APOA1 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-3µg/mL;
Immunohistochemistry: 5-30µg/mL;
Immunocytochemistry: 5-30µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| European Journal of Applied Physiology | Endurance training enhances ABCA1 expression in rat small intestine PubMed: 19629515 |
| Official Journal of the INWR | Effect of eight weeks of wrestling and circuit fitness training on Apo lipoportein A-I and lymphocyte ABCA1 gene expression in well-trained wrestler. Wrestling: source |
| Biochemical and Biophysical Research Communications | Treadmill exercise enhances ABCA1 expression in rat liver ScienceDirect: S0006291X0701488X |
| World Journal of Sport Sciences | The Effect of Eight Weeks of Wrestling and Wrestling Technique Based Circuit Training on Lymphocyte ABCA1 Gene Expression and Plasma Apolipoprotein A-1 Idosi: source |
| Biochimica et Biophysica Acta | Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties PubMed: 23328279 |
| Biomarkers | The association of a distinct plasma proteomic profile with the cervical high-grade squamous intraepithelial lesion of Uyghur women: a 2D liquid-phase chromatography/mass spectrometry study PubMed: 22458349 |
| Journal of the American Heart Association | MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE?/? Mice PubMed: PMC3540673 |
| PLoS ONE | Apolipoprotein AI Is a Potential Mediator of Remote Ischemic Preconditioning Plosone: Source |
| Molecular Genetics and Metabolism | DYRK1A overexpression decreases plasma lecithin: cholesterol acyltransferase activity and apolipoprotein AI levels Pubmed: 23920041 |
| Endocrinology | Deficiency of Clusterin Exacerbates High-Fat Diet-Induced Insulin Resistance in Male Mice Pubmed: 24684302 |
| Molecular Genetics and Metabolism Reports | Corrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia Sciencedirect:S2214426915000026 |
| J Psychopharmacol | Anti-atherogenic properties of high-density lipoproteins in psychiatric patients before and after two months of atypical anti-psychotic therapy PubMed: 26253619 |
| Biochim Biophys Acta | Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism PubMed: 26515253 |
| Pharmacol Res Perspect | Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer PubMed: 26171234 |
| Clin Exp Nephrol | Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome PubMed: 26351173 |
| Oncogene | Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis PubMed: 26279300 |
| Oncogene | Apolipoprotein AI inhibits experimental colitis and colitis-propelled carcinogenesis Pubmed:26279300 |
| Allergy | Serum levels of 9α,11β-PGF2 and apolipoprotein A1 achieve high predictive power as biomarkers of anaphylaxis. pubmed:28378321 |
| Journal of Chromatography A | Application of a new procedure for liquid chromatography/mass spectrometry profiling of plasma amino acid-related metabolites and untargeted shotgun proteomics to identify mechanisms and biomarkers of calcific aortic stenosis S0021967317311858 |
| 11 | High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-kB/STAT1-IRF1 Signaling pubmed:27866837 |
| Biomedical Science Letters | Effect of Ginkgo biloba Extract (EGb 761) on Serum Cholesterol Levels in Wild-type C57Bl/6 Mice 10.15616/BSL.2017.23.2.80 |
| ACS Biomaterials Science & Engineering | Enhanced Antiatherosclerotic Efficacy of Statin-Loaded Reconstituted High-Density Lipoprotein via Ganglioside GM1 Modification abs:10.1021 |
| Food Research International | Wild Lonicera caerulea berry polyphenol extract reduces cholesterol accumulation and enhances antioxidant capacity in vitro and in vivo Pubmed:29580541 |
| Journal of The Science of Food and Agriculture | Consumption of orange fermented beverage improves antioxidant status and reduces peroxidation lipid and inflammatory markers in healthy humans Pubmed:29124773 |
| Toxicon | A membrane disrupting toxin from wasp venom underlies the molecular mechanism of tissue damage Pubmed:29654869 |
| European Journal of Pharmacology | The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in?… Pubmed: 30768981 |
| European Journal of Preventive Cardiology | High-intensity interval training has a greater effect on reverse cholesterol transport elements compared with moderate-intensity continuous training in obese male rats Pubmed: 31718266 |
| Diagnostics | Systemic Alterations of Immune Response-Related Proteins during Glaucoma Development in the Murine Model DBA/2J Pubmed: 32585848 |
| VETERINARY PATHOLOGY | Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats Pubmed: 32880234 |
| Nat Commun | GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity 34853313 |
| Cardiovasc Toxicol | Interplay of Obesity, Ethanol, and Contaminant Mixture on Clinical Profiles of Cardiovascular and Metabolic Diseases: Evidence from an Animal Study Pubmed:35429258 |
| Peptides | Neuropeptide Y promotes hepatic apolipoprotein A1 synthesis and secretion through neuropeptide Y Y5 receptor Pubmed:35660638 |
| Journal of Functional Foods | Castanea mollissima shell polyphenols regulate JAK2 and PPARγ expression to suppress inflammation and lipid accumulation by inhibiting M1 macrophages … |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| APA519Hu01 | Active Apolipoprotein A1 (APOA1) | Cell culture; Activity Assays. |
| RPA519Hu01 | Recombinant Apolipoprotein A1 (APOA1) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA519Hu01 | Polyclonal Antibody to Apolipoprotein A1 (APOA1) | WB; IHC; ICC; IP. |
| LAA519Hu71 | Biotin-Linked Polyclonal Antibody to Apolipoprotein A1 (APOA1) | WB; IHC; ICC. |
| MAA519Hu21 | Monoclonal Antibody to Apolipoprotein A1 (APOA1) | WB; IHC |
| MAA519Hu24 | Monoclonal Antibody to Apolipoprotein A1 (APOA1) | WB; IHC; ICC; IP. |
| MAA519Hu26 | Monoclonal Antibody to Apolipoprotein A1 (APOA1) | WB; IHC; ICC; IP. |
| MAA519Hu23 | Monoclonal Antibody to Apolipoprotein A1 (APOA1) | WB; IHC; ICC; IP. |
| MAA519Hu25 | Monoclonal Antibody to Apolipoprotein A1 (APOA1) | WB; IHC; ICC; IP. |
| RAA519Hu21 | Recombinant Antibody to Apolipoprotein A1 (APOA1) | WB; IHC; ICC. |
| RAA519Hu27 | Recombinant Antibody to Apolipoprotein A1 (APOA1) | WB; IF; ICC; IHC; IP; FCM. |
| MAA519Hu22 | Monoclonal Antibody to Apolipoprotein A1 (APOA1) | WB; IHC; ICC; IP. |
| LAA519Hu76 | Biotin-Linked Monoclonal Antibody to Apolipoprotein A1 (APOA1) | WB; IHC; ICC. |
| SEA519Hu | ELISA Kit for Apolipoprotein A1 (APOA1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| AEA519Hu | ELISA Kit for Anti-Apolipoprotein A1 Antibody (Anti-APOA1) | Enzyme-linked immunosorbent assay for Antibody Detection. |
| SCA519Hu | CLIA Kit for Apolipoprotein A1 (APOA1) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA519Hu | Magnetic Luminex Assay Kit for Apolipoprotein A1 (APOA1) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
| PSA519Hu01 | Antibody Pair for Apolipoprotein A1 (APOA1) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA519Hu01 | ELISA Kit DIY Materials for Apolipoprotein A1 (APOA1) | Main materials for "Do It (ELISA Kit) Yourself". |
Share
